Objective: Recently, the role of long noncoding RNAs (lncRNAs) in human colorectal cancer (CRC) has been a subject of intense focus. We set out to determine the function of one lncRNA, termed urothelial carcinoma-associated 1 (UCA1) in CRC cell proliferation and its underlying mechanisms. Methods: Quantitative real-time PCR (qRT-PCR) was applied to detect the expression level of UCA1 in 50 pairs of CRC samples compared with non-tumor colon tissues. Cell growth was determined using the Cell Counting Kit-8 (CCK-8). Western blotting was carried out to analyze the related protein expression. Flow cytometry was done to evaluate cell apoptosis by UCA1 inhibition. Results: We found an increased expression of UCA1 in CRC samples. Knockdown of UCA1 in HCT116 cells induced a decrease in cell proliferation rate compared to control samples. This oncogenic activity may be enhanced through p53/ p21 signaling. Conclusion: Our results supported the hypothesis that upregulation of UCA1 contributes to the unlimited proliferation rate of CRC cells, at least partially through the negative regulation of p53/p21 signaling pathway. Finally, we found that UCA1 merely influenced CRC cell apoptosis.
Introduction
Colorectal cancer (CRC) is one of the most common types of human tumor malignancies the worldwide, affecting more than one million individuals every year [1] . Despite recent advances in surgical resection, radiotherapy, and chemotherapy have improved clinical outcomes for patients, it remains the third leading cause of cancerrelated death in the United States in both males and females [2] . The prognosis of advanced-staged patients also remains poor [3] . Accordingly, more attention should be paid to the development as well as the implementation of novel and efficient biomarkers for early detection and therapy. Meanwhile, the underlying oncogenic signaling mechanisms should also be elucidated for these candidate CRC targets [4, 5] .
The lncRNAs are important newly discovered members of non-coding RNAs (ncRNAs), which have a length of more than 200 nucleotides (nt). They do not encode proteins but can do participate in a wide range of biological processes [6] [7] [8] . The particular function of lncRNAs that attracts attention and research is their vital involvement in carcinogenesis [9] [10] [11] . Emerging evidence suggests that lncRNAs might serve as master gene regulators by controlling both protein-coding and nonprotein-coding genes [12] . They have a critical role in the regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis [13] . Dysregulation and aberrant expression of certain lncRNAs have the potential to be used as early detection biomarkers as well as prognosis predictors in cancer, including CRC [14] [15] .
UCA1 was identified as the most sensitive and specific lncRNA upregulated in bladder carcinoma [16] . Its fulllength cDNA is 1442 bp. Forced expression of UCA1 in bladder cancer cells lead to enhanced proliferative, migrative, invasive, and drug resistance behaviors in vitro and increased tumorigenic potential of BLS-211 cells in nude mice [17] [18] . However, its contribution in CRC has remained largely unknown until recently. Han et al into 96-well plates at a density of 2,000 cells in 200 μl of medium per well and then incubated at 37°C for four days Absorbance was detected at 490 nm using a microplate reader.
Flow cytometric analysis
The cell cycle and apoptosis rate were evaluated by fluorescence-activated cell sorting (FACS) analysis of propidium iodide-stained nuclei. After transfection of control siRNA or UCA1 siRNA, cells were stained with propidium iodide (Sigma), and the cell cycle and apoptosis rate was analyzed by flow cytometry (FACSCalibur) according to the manufacturers' protocol.
Western blot analysis
Cells were washed twice with cold PBS and lysed in RIPA buffer containing protease inhibitors. Total protein extracts were resolved on 12% SDS polyacrylamide gel and electrotransferred to polyvinylidene fluoride membranes. The membranes were blocked in 5% non-fat dry milk in PBST and then immunoblotted with p53, p21 and tubulin antibodies (Santa Cruz, USA) at 4°C overnight followed by HRP-labeled secondary antibody and detected by chemiluminescence. Tubulin expression was used as the loading control.
Statistical analysis
Student's t-test (two-tailed), was used to analyze data, along with GraphPad v5.0.1. P values of less than 0.05 were considered statistically significant.
Results

UCA1 was increased in paired colorectal cancer tissues
At the onset of our study, we first carried out qRT-PCR analysis to measure the expression of lncRNA UCA1 in 50 CRC tissues and 50 matched normal colorectal tissues. The results in Figure 1 show that the expression of UCA1 was significantly upregulated in cancerous CRC tissues compared with matched non-tumor colorectal tissues (P = 0.0385). These results demonstrat that UCA1 may be a good diagnostic biomarker for early-stage CRC. This observation showed that UCA1 was upregulated and influenced cell proliferation, apoptosis and cell cycle distribution in CRC cells [19] . Nevertheless, the underlying mechanism is still poorly understood. In the present study, we examined the expression of UCA1 in CRC tissues or cell lines compared to adjacent normal tissues or normal cell lines. To access its function in CRC cells, and we quantified cell proliferation rates during overexpression. Finally, we used Western blot to determine the expression of p53/p21 signaling molecules. This study enriches our understanding of the role of UCA1 as a regulator of the tumorigenesis of CRC and facilitates the development of lncRNA for future studies in CRC.
Materials and Methods
Tissues and Cell Lines
CRC tissues and adjacent normal tissues from 55 CRC patients were collected from the Shaoxing People's Hospital. The tumor tissues contained 80-90% cancer cells, whereas the paired adjacent normal tissues were isolated from at least 5cm away from the tumor border. Informed consent was obtained from participants for the use of their tissues in this paper.
The Human CRC HCT116 cell line was obtained from the American Type Culture Collection (USA). HCT116 cells were maintained routinely in Dulbecco's modified Eagle's medium supplemented with 10% FBS and 2 mM L-glutamine (Invitrogen, USA) and were grown at 37°C in a 10% CO 2 atmosphere.
Quantitative Real-time PCR
Total RNA was extracted by TRIzol reagent (Invitrogen) following the manufacture's instruction. Then, 2 μg RNA were reverse transcribed from each sample to synthesis cDNA. Quantitative real-time PCR was employed to determine the relative expression level of target genes by the SYBR Premix ExTaq II kit (Takara) on the ABI7900. The relative amount of UCA1 to U6B was calculated using the equation 2 -∆CT , where ∆CT = CT UCA1 -CT U6B .
CCK-8 Assay
The CCK-8 assay was used in this study. HCT116 cells transfected with control siRNA or UCA1 siRNA (Gene Pharma, Shanghai, China), were trypsinzed and seeded inhibit the endogenous expression of UCA1 in HCT116 cells. CCK-8 assay was used to determine the impact of UCA1 knockdown on cell proliferation. According to the results shown in Figure 2A , the efficiency of siRNA-mediated inhibition of endogenous UCA1 reached about 80%. Most importantly, the data presented in Figure 2B revealed a marked slow-down of cell growth rate in UCA1-deleted cells than control cells. These observations made with the UCA1-targetted siRNA indicate that UCA1 is involved in CRC progression by promoting cell proliferation.
Knockdown of UCA1 induced G1 arrest by targeting p53/p21 signaling
Since we have proved above that UCA1 could promote cell proliferation, does this effect come true by regulating cell cycle distribution? To answer this question, we analyzed the cell cycle progression in the above referred UCA1-kncokdown HCT116 cells and the control cells with fluorescence-activated cell sorting (FACS) analysis of propidium iodide-stained nuclei. As expected, after UCA1 was inhibited by siRNA, the results demonstrat a significant accumulation of cells at G0/G1-phase and a remarkable decrease in S-phase compared with control cells (Figure 3A) . It is well known that p53/p21 signaling is a vital pathway that controls the cell cycle as well as cell proliferation processes. We then investigated the growth is in line with the previous report that considered UCA1 as an oncogenic lncRNA in CRC cells [19] . Our results support this, although functional phenotypes was lacking.
The effect of UCA1 inhibition on cell proliferation and cell cycle distribution of HCT116 cells
To further explore the biological functions of UCA1 in CRC cells, HCT116 cells were selected for functional analysis. We used a small interfering RNA (siRNA) that targeted UCA1 to normal cells, and their dysregulation could affect cell proliferation, apoptosis, autophagy, migration and metastasis. Our findings strongly suggest that lncRNAs could be used as a novel class of biomarkers as well as therapeutic targets for at least some types of cancers [22] .
UCA1 has previously been identified as a novel biomarker for bladder cancer [23] . In breast cancer, UCA1 was also shown to promote cell growth and cell cycle progression by targeting p27 expression [24] . Most importantly, UCA1 RNA stability could be enhanced by splicing factor hnRNP I [24] . UCA1 also had significantly increased concentrations in gastric cancer tissues and cell lines, and its expression correlated with both poorer differentiation and increased patient mortality. This suggests that UCA1 could be considered as an independent prognostic biomarker [25] . Combining this previously reported information with the results of our current study, it is highly likely that UCA1 might serve as a promising biomarker for the early detection and prognosis prediction of several types of cancers. To explore the underlying mechanisms governing the oncogenic functions of UCA1 in CRC HCT116 cells, we analyzed p21 and p53 protein inhibitory effect of UCA1-knockdown. Western blotting was performed to detect the expression of p53 and p21 protein expression. As shown in Figure 3B , the expression level of p53 was significantly increased whereas p21 was slightly increased in the UCA1-inhibited cells. The results suggested that the effect of UCA1 in CRC cells is at least in part through regulating p53/p21 signaling. Additionally, we also performed FACS analysis of cell apoptosis in the same HCT116 cells with or without UCA1 siRNA treatment. The results shown in Figure 3C demonstrated that there was no significant difference in apoptosis rates between control and UCA1 siRNA.
Discussion
During the last few years, lncRNAs have appeared more frequently in the cancer research area. They can be transcribed by RNA polymerase II (RNA pol II) and are polyadenylated [20] . They are emerging as novel and key regulators of gene expression and cell fates [21] . Indeed, aberrant expression of lncRNAs has been found in various kinds of cancers when compared with respective expression in UCA1-deleted cells. We found that after UCA1 was silenced by targeting siRNA, the expression of p21 protein did not change significantly, but p53 protein concentrations were significantly increased in the treatment group compared with the control group. p21 is known as a universal inhibitor, which plays a role through the p53-dependent and -independent pathways, resulting in cell cycle arrest at the G1 checkpoint and inhibition of further cell proliferation. However, it remains unclear whether or not this regulation is direct. Future studies should aim to characterize the details of the oncogenic mechanisms involved with UCA1 function and regulation, both in vivo and in vitro .
In summary, this present study demonstrates that concentrations of UCA1 are decreased in CRC clinical tissues. The effects of this lncRNA on cell proliferation and cell cyle progression suggest that it is involved in CRC tumorigenesis. Finally, we conclude that UCA1 may regulate cell proliferation by targeting p53/p21 signaling.
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